The Blacklist: “The Longevity Initiative”
(Episode 2.17)

Back when The Blacklist premiered, almost two years ago, it played like a show going for a very The Silence of the Lambs vibe. As the first few episodes passed, it became clear that The Blacklist was far too bland to warrant such a comparison. The further the show went, I wished that it would head more in an Alias direction, where the show could allow itself to have fun, introduce crazy ideas and generally go nuts. “The Longevity Initiative” is the closest The Blacklist has gotten to mirroring the great Alias, but after seeing its best attempt at that, maybe it’s not such a good idea after all.
The Longevity Initiative might be our most Bond villain-y Blacklisters yet, as they’re a company led by a tech billionaire (Roger Hobbs) trying to figure out how to achieve immortality. While The Blacklist can sometimes get insane, it’s never quite jumped to the mystical level of a bunch of doctors trying to live forever, so right away the plot just doesn’t match the show thematically. One of the doctors for The Longevity Initiative (Dr. Julian Powell) has been stealing people with brain injuries from care facilities in order to test his work on them, often cutting open the frontal lobe to try out his experiments.
By the end of the episode, we of course discover that Dr. Powell hasn’t found any way to allow for immortality, and that he’s actually been using Hobbs’ money to fund his own research—trying to restore the memory of his fiancée after a car accident left her with severe brain damage.
The larger scope of the episode doesn’t mesh at all with the direction this show usually goes in, to the point that there’s never any real way to believe that anyone will discover the fountain of youth. It’s sort of like the theories about how Cthulhu might show up on True Detective, or that characters from Breaking Bad might have super powers; it’s fun to think about, and it would be insane if it happened, but it also would be a complete 180 for the shows.